TRUBION PHARMACEUTICALS, INC.
Patent Applications and Registrations
Patent applications and USPTO patent grants for TRUBION PHARMACEUTICALS, INC..The latest application filed is for "materials and methods for improved immunoglycoproteins".
- TRUBION PHARMACEUTICALS, INC. - Seattle WA
- TRUBION PHARMACEUTICALS, INC. - 2401 4th Avenue Suite 1050 Seattle WA
| Patent | Date |
|---|---|
| Materials And Methods For Improved Immunoglycoproteins App 20110256125 - ESPLING; Erik S. ; et al. | 2011-10-20 |
| Cd37 Immunotherapeutic And Combination With Bifunctional Chemotherapeutic Thereof App 20110171208 - Tan; Philip ; et al. | 2011-07-14 |
| Binding Domain-immunoglobulin Fusion Proteins App 20110105729 - Ledbetter; Jeffrey A. ; et al. | 2011-05-05 |
| Binding Domain-immunoglobulin Fusion Proteins App 20110091461 - Ledbetter; Jeffrey A. ; et al. | 2011-04-21 |
| Single-chain Multivalent Binding Proteins With Effector Function App 20110033483 - Thompson; Peter Armstrong ; et al. | 2011-02-10 |
| Anti-cd20 Therapeutic Compositions And Methods App 20100330089A1 - | 2010-12-30 |
| Materials and methods for improved immunoglycoproteins Grant 7,846,434 - Espling , et al. December 7, 2 | 2010-12-07 |
| Binding constructs and methods for use thereof Grant 7,829,084 - Ledbetter , et al. November 9, 2 | 2010-11-09 |
| Binding Constructs And Methods For Use Thereof App 20100279932 - LEDBETTER; JEFFREY A. ; et al. | 2010-11-04 |
| Binding Domain-immunoglobulin Fusion Proteins App 20100203052 - Ledbetter; Jeffrey A. ; et al. | 2010-08-12 |
| Binding domain-immunoglobulin fusion proteins Grant 7,754,208 - Ledbetter , et al. July 13, 2 | 2010-07-13 |
| Materials And Methods For Improved Immunoglycoproteins App 20100150948 - Baum; Peter Robert ; et al. | 2010-06-17 |
| Cd37 Immunotherapeutic Combination Therapies And Uses Thereof App 20100135900 - CERVENY; CHARLES G. ; et al. | 2010-06-03 |
| Binding Domain-immunoglobulin Fusion Proteins App 20100034820 - Ledbetter; Jeffrey A. ; et al. | 2010-02-11 |
| Cd37 Immunotherapeutic And Combination With Bifunctional Chemotherapeutic Thereof App 20090274692 - Tan; Phillip ; et al. | 2009-11-05 |
| Therapeutic compositions and methods App 20090258005 - Gill; Davinder ; et al. | 2009-10-15 |
| B-cell Reduction Using Cd37-specific And Cd20-specific Binding Molecules App 20090214539 - Grosmaire; Laura S. ; et al. | 2009-08-27 |
| Binding Constructs And Methods For Use Thereof App 20090196870 - Ledbetter; Jeffrey A. ; et al. | 2009-08-06 |
| Single-Chain Multivalent Binding Proteins with Effector Function App 20090175867 - Thompson; Peter A. ; et al. | 2009-07-09 |
| Binding Peptides Having a C-terminally Disposed Specific Binding Domain App 20090148447 - Ledbetter; Jeffrey A. ; et al. | 2009-06-11 |
| Materials and methods for improved immunoglycoproteins App 20090041765 - Espling; Erik S. ; et al. | 2009-02-12 |
| B-Cell Reduction Using CD37-Specific and CD20-Specific Binding Molecules App 20080279850 - Brady; William ; et al. | 2008-11-13 |
| Binding Proteins Comprising Immunoglobulin Hinge And Fc Regions Having Altered Fc Effector Functions App 20080227958 - Thompson; Peter Armstrong ; et al. | 2008-09-18 |
| Single dose use of CD20-specific binding molecules App 20080213273 - Burge; Daniel J. | 2008-09-04 |
| B-cell reduction using CD37-specific and CD20-specific binding molecules App 20070059306 - Grosmaire; Laura S. ; et al. | 2007-03-15 |
| Compositions And Methods For Protein Deaggregation App 20070021591 - Movius; Arthur James IV ; et al. | 2007-01-25 |
| DNA vaccines encoding antigen linked to a domain that binds CD40 Grant 7,118,751 - Ledbetter , et al. October 10, 2 | 2006-10-10 |
| Binding domain-immunoglobulin fusion proteins App 20050238646 - Ledbetter, Jeffrey A. ; et al. | 2005-10-27 |
| Binding domain-immunogloubulin fusion proteins App 20050202012 - Ledbetter, Jeffrey A. ; et al. | 2005-09-15 |
| Binding domain-immunoglobulin fusion proteins App 20050202028 - Ledbetter, Jeffrey A. ; et al. | 2005-09-15 |
| Binding domain-immunoglobulin fusion proteins App 20050202534 - Ledbetter, Jeffrey A. ; et al. | 2005-09-15 |
| Binding domain-immunoglobulin fusion proteins App 20050202023 - Ledbetter, Jeffrey A. ; et al. | 2005-09-15 |
| Binding domain-immunoglobulin fusion proteins App 20050186216 - Ledbetter, Jeffrey A. ; et al. | 2005-08-25 |
| Binding domain-immunoglobulin fusion proteins App 20050180970 - Ledbetter, Jeffrey A. ; et al. | 2005-08-18 |
| Binding domain-immunoglobulin fusion proteins App 20050175614 - Ledbetter, Jeffrey A. ; et al. | 2005-08-11 |
| NCAGE Code | 610H5 | TRUBION PHARMACEUTICALS, INC. |
| CAGE Code | 610H5 | TRUBION PHARMACEUTICALS, INC. |
| SEC | 0001298524 | Trubion Pharmaceuticals, Inc |
| SEC | 0001298521 | Trubion Pharmaceuticals, Inc of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 